As previous studies showed that TRIM24 expression is up-regulated in breast cancer, myelodysplastic syndrome-related acute myeloid leukemia and sporadic colorectal cancers [13], [19], [20], our results support that aberrant expression of TRIM24 is common in multiple tumor types and may contribute to initiation and/or progression of these tumors. Here, TRIM24 is linked to neoplasm.